Cambridge Investment Research Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Buy |
|
|||||
|
2025
Q1 | $92K | Buy |
|
|||||
|
2024
Q4 | $118K | Sell |
|
|||||
|
2024
Q3 | $172K | Buy |
|
|||||
|
2024
Q2 | $152K | Sell |
|
|||||
|
2024
Q1 | $118K | Sell |
|
|||||
|
2023
Q4 | $73K | Sell |
|
|||||
|
2023
Q3 | $80K | Sell |
|
|||||
|
2023
Q2 | $79K | Sell |
|
|||||
|
2023
Q1 | $96K | Buy |
|
|||||
|
2022
Q4 | $299K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $177K | Sell |
|
|||||
|
2021
Q1 | $206K | Sell |
|
|||||
|
2020
Q4 | $183K | Sell |
|
|||||
|
2020
Q3 | $197K | Buy |
|
|||||
|
2020
Q2 | $275K | Sell |
|
|||||
|
2020
Q1 | $227K | Sell |
|
|||||
|
2019
Q4 | $287K | Sell |
|
|||||
|
2019
Q3 | $267K | Buy |
|
|||||
|
2019
Q2 | $517K | Buy |
|
|||||
|
2019
Q1 | $447K | Buy |
|
|||||
|
2018
Q4 | $347K | Sell |
|
|||||
|
2018
Q3 | $724K | Buy |
|
|||||
|
2018
Q2 | $234K | Buy |
|
|||||
|
2018
Q1 | $400K | Buy |
|
|||||
|
2017
Q4 | $219K | Buy |
|